- Do not use in cats suffering from gastrointestinal ulceration.
- Do not use concomitantly with corticosteroids or other non-steroidal anti-inflammatory drugs (NSAIDs).
- Do not use in case of hypersensitivity to the active substance or to any of the excipients.
- Do not use in pregnant and lactating animals.
The safety of the veterinary medicinal product has not been established in cats weighing less than 2.5 kg or under 4 months of age.
Use in cats with impaired cardiac, renal or hepatic function or in cats that are dehydrated, hypovolaemic or hypotensive may involve additional risks. If use cannot be avoided, these cats require careful monitoring.
Response to long-term treatment should be monitored at regular intervals by a veterinary surgeon.
Clinical field studies showed that robenacoxib was well-tolerated by most cat for up to 12 weeks.
Use this veterinary medicinal product under strict veterinary monitoring in cats with a risk of gastrointestinal ulcers, or if the cat previously displayed intolerance to other NSAIDs.
For more information, please use the following link: http://www.noahcompendium.co.uk/?id=-462371